S Pyrhönen1. Show Affiliations » 1. Department of Oncology and Radiotherapy, Turku University Central Hospital, Turku, Finland. seppo.pyrhonen@tyks.fi
Abstract
Mesh: See more » Antineoplastic Agents, Phytogenic/adverse effectsAntineoplastic Agents, Phytogenic/therapeutic useCarcinoma, Renal Cell/drug therapyCarcinoma, Renal Cell/immunologyCarcinoma, Renal Cell/mortalityCarcinoma, Renal Cell/pathologyDrug Administration ScheduleDrug Therapy, CombinationHumansImmunologic Factors/adverse effectsImmunologic Factors/therapeutic useInterferon-alpha/adverse effectsInterferon-alpha/therapeutic useKidney Neoplasms/drug therapyKidney Neoplasms/immunologyKidney Neoplasms/mortalityKidney Neoplasms/pathologyNeoplasm StagingRandomized Controlled Trials as TopicSurvival RateVinblastine/adverse effectsVinblastine/therapeutic use
Substances: See more » Antineoplastic Agents, PhytogenicImmunologic FactorsInterferon-alphaVinblastine
Year: 2004 PMID: 15148576 DOI: 10.1007/s00120-004-0604-8
Source DB: PubMed Journal: Urologe A ISSN: 0340-2592 Impact factor: 0.639